Programme and Presentations

UK & Ireland Prostate Brachytherapy Conference 2019

Friday 22nd March 2019

Royal Armouries Museum, Leeds, West Yorkshire, LS10 1LT

    ABSTRACT SLIDES  
08:30 Registration      
09:00 Welcome     Ann Henry, Leeds
09:10 Molecular Imaging in Prostate Cancer – Current Status and Future Prospects   Andy Scarsbrook, Leeds
09:40 Biofocussed prostate cancer RadioTherapy (BiRT)   Annette Haworth, Australia
10:20 Coffee; Exhibition/Poster viewing
10:50 Optimal fractionation in HDR brachytherapy   Gerard Morton, Canada
11:30 Minimising and managing morbidity in LDR brachytherapy   Mira Keyes, Canada
12:10 Patient contamination in prostate LDR brachytherapy   Sarah Aldridge, London
12:30 Lunch; Exhibition/Poster viewing
13:30 Proffered papers – Clinical     Chairs: Annette Haworth
and Gerard Morton
14:15 Breakout sessions
  Physics: Verification/Uncertainties Theme     Chair: Peter Bownes, Leeds
  Differences in dosimetry, planning and equieffective doses for prostate brachytherapy   Annette Haworth, Australia
  In-vivo dosimetry in clinical practice   Joshua Mason, Victoria Coleman, Leeds
  Proffered papers – Physics      
  Clinical: Toxicity Theme     Chair: Sree Rodda, Leeds
  Screening for and managing radiation bowel toxicity   John Staffurth, Cardiff
  Medical management of sexual dysfunction     Ian Eardley, Leeds
  Management of psycho-sexual dysfunction after prostate cancer treatment   Lorraine Grover, London
  Abstracts
  LDR versus HDR brachytherapy boost in prostate cancer patients – a retrospective analysis   Sree Rodda
  Pre-operative membranous urethral length predicts early return of continence in patients undergoing salvage robotic assisted radical prostatectomy   Sadat Yazdouni
  Outcomes from intermediate risk, Gleason 7, localised prostate cancer treated with low-dose rate brachytherapy   Robert Maher
  Salvage High Dose Brachytherapy at the Bristol Cancer Institute – Experience and Challenges   Susan Masson
  The Design and Development of Patient-based Anthropomorphic Prostate Training Devices for Novice Oncologists for Trans rectal Ultrasound (TRUS) Guided Prostate Imaging   Andrea J Doyle
  Robotic Prostate Biopsy and LDR/HDR Brachytherapy under MRI Guidance: Update from the EU-funded CoBra Project   Sarah Wilby
  Acute urinary toxicity following HDR brachytherapy for prostate cancer: comparing outcomes with CT only treatment planning versus CT and MRI   Emily Farrow
  Patient satisfaction and patient reported outcomes (PROMS) following HDR brachytherapy for prostate cancer at the Sussex Cancer Centre   Ashok Nikapota
15:45 Coffee; Exhibition/Poster viewing
16:15 Debate:
Which is best: LDR or HDR boosting when combining with EBRT?
  Chair: David Bottomley, Leeds
Gerard Morton, Canada
and Mira Keyes, Canada
17:00 Closing remarks and presentation of prizes     Ann Henry and Peter Bownes,
Leeds
Evening Conference Dinner      

< back to archive